Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Agrisera is a Swedish life science tools company focused on the production, purification, labeling, and commercialization of antibodies and related reagents for plant and algal research. Founded in 1985, the company built a niche position in research-use antibodies for plant cell biology, photosynthesis, cell compartments, cell wall biology, hormones, and related applications, and it also offers secondary antibodies, detection reagents, and ELISA quantitation kits. Agrisera sells catalog products globally and emphasizes broad species reactivity, validation in independent laboratories, and technical support for academic and research customers. The business operates commercially rather than as a therapeutic drug developer, so it does not have a clinical pipeline in the biotech sense. Since July 2024, Agrisera has been part of Thermo Fisher Scientific.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Agrisera.